These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 688)

  • 21. [Comparative study on the effects of alprenolol, bunitrolol, ethaverine, oxprenolol, papaverine, practolol, pindolol, pronethalol, propranolol, toliprolol and verapamil on cardiac and bronchial beta-receptors (author's transl)].
    Wuppermann D; Zimmermann F; Friedrich L
    Arzneimittelforschung; 1978; 28(5):794-8. PubMed ID: 35172
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmacology of atenolol.
    Barrett AM
    Postgrad Med J; 1977; 53 Suppl 3():58-64. PubMed ID: 928267
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
    Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
    Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].
    Bartsch R; Merbt EM; Riedel H
    Pharmazie; 1975 Oct; 30(10):659-68. PubMed ID: 691
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 30. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacology of the optically active isomers of talinolol (cordanum) 2].
    Femmer K; Poppe H
    Pharmazie; 1982 Jul; 37(7):505-8. PubMed ID: 6127726
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 35. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
    Weinstock M; Schechter Y; Erez M; Shtacher G
    Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat.
    Levy B
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):143-6. PubMed ID: 4147749
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.